# Pre-Build Product Readiness Review

**Reviewed:** 2026-08-27 · **Decision:** ready for controlled stabilization, not ready for broad parallel build.

## Scorecard

| Area                        |  Score | Assessment                                                                |
| --------------------------- | -----: | ------------------------------------------------------------------------- |
| Product concept             | 9.3/10 | Clear clinic-guided handbook plus differentiated 3D discovery             |
| PRD and scope               | 9.1/10 | Strong journeys, exclusions, safety, and success criteria                 |
| UX definition               | 8.8/10 | Core flows are clear; safety parity and search details need closure       |
| Clinical governance         | 7.2/10 | Strong rules; human approvals and review metadata remain open             |
| Architecture                | 8.2/10 | Appropriate static-first approach; 3D implementation contract needs proof |
| Visual/media plan           | 8.7/10 | Still-first and motion safeguards are strong                              |
| Multi-agent readiness       | 6.4/10 | Previous handoffs were detailed but stale and over-fragmented             |
| Build verification          | 5.0/10 | Declared checks are not yet trustworthy in the installed environment      |
| Overall pre-build readiness | 8.0/10 | Start S0; do not start every module simultaneously                        |

## What is complete enough to build

- Product positioning, audiences, three entry paths, exclusions, privacy model, and static architecture.
- Handbook workflow through stable URL, QR, print, browsing, and visual discovery.
- Clinical-content ownership, draft/published lifecycle, compliance boundary, and no-diagnosis rule.
- 3D progressive enhancement, fallback behavior, performance budgets, asset review, and motion rules.
- Design foundations, 17px base type, head-to-toe ordering, responsive and accessibility principles.

## Must close before broad parallel work

1. Make the check suite executable and record a clean/failing fixture result.
2. Preserve both untracked folders in git before branches or worktrees.
3. Resolve duplicate decision IDs in `memory.md` so references are unambiguous.
4. Mark old M0–M9 handoffs historical or re-baseline them before reuse.
5. Establish one current ownership matrix and one supervisor acceptance protocol.
6. Prevent unreviewed published rows and draft safety copy from patient routes.
7. Decide one safety rule for direct links versus locator use.
8. Remove inferred item priority and unpublished “Coming soon” cards.

## Human decisions required

- Regulatory classification and accountable approver.
- Emergency destination and exact stop-screen wording.
- Final disclaimer wording.
- Media route: licensed, controlled 3D render, or constrained AI; plus visual style.
- Clinician approval of body-region highlights.
- Production domain.
- Whether “start here” exists and how it is selected in the sheet.
- Whether area pages remain flat or gain dedicated exercise detail pages.

## Product improvements recommended

- Add clinic mode as a quiet utility view, not an account system.
- Add approved search synonyms only; never infer or search by condition.
- Put canonical share controls at area and item level with QR/print parity.
- Let 3D improve discovery without becoming mandatory or implying diagnostic precision.
- Instrument quality through offline usability tests and task completion, not analytics.
- Treat visual assets as clinical content: provenance, version, approval, and rejection reason.

## Go decision

Proceed with **S0 Stabilization** immediately. Start S1 and V1 only after the supervisor verifies S0.
Do not generate the full image corpus or full 3D body before one reviewed region proves the workflow,
performance budget, accessibility fallback, and clinician visual-accuracy process.
